Carbamate → HCID 178420766, compound
Reaction equation
[NH:1]1[CH:6]=[CH:5][CH2:4][CH2:3][CH2:2]1.[PH:7](=[O:14])([O:11][CH2:12][CH3:13])[O:8][CH2:9][CH3:10].C(=O)([O-])N.[O-]S(C(F)(F)F)(=O)=O>>[NH:1]1[CH:2]=[CH:3][CH2:4][CH2:5][CH2:6]1.[PH:7](=[O:14])([O:11][CH2:12][C:13]1[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1)[O:8][CH2:9][C:10]1[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1Participants
4
Procedure
The tetrahydropyridine-dibenzyl phosphonate 13: The compound 13 was obtained by the same procedure as described for compound 11 using the pyridine 9 (10.0 mg, 0.018 mmol) and the triflate 12 (9.4 mg, 0.022 mmol). The product 13 was purified by preparative TLC to afford the dibenzyl phosphonate 13 (8.8 mg, 59%): 1H NMR (CDCl3) δ 7.73 (d, 2H, J=8.7 Hz), 7.35 (s, 10H), 7.00 (d, 2H, J=8.7 Hz), 5.65 (d, 1H2H, J=5.1 Hz), 5.39 (br, 1H), 5.15-4.92 (m, 6H), 4.03-3.77 (m, 6H), 3.77-3.62 (m, 2H), 3.56 (br, 1H), 3.24-2.62 (m, 9H), 2.32 (d, 1H, J=13.5 Hz), 2.24-1.75 (m, 6H), 0.94 (d, 3H, J=6.6 Hz), 0.89 (d, 3H, J=6.3 Hz); 31P NMR (CDCl3) δ 25.5; MS (ESI) 842 (M+H).
Workup
- customThe product 13 was purified by preparative TLC
Sources & evidence
- ORD record
- ord-56fb06eeec4d411f88404354f5a43599
- Source dataset
- uspto-grants-2010_01
- Patent number
- US07649015B2
Reaction notes
Loading…